Advertisement

Topics

HEMARINA Company Profile

06:37 EDT 22nd October 2018 | BioPortfolio


News Articles [2 Associated News Articles listed on BioPortfolio]

Hemarina SA Product Pipeline Analysis, 2018 Update [Report Updated: 16052018] Prices from USD $750

SummaryHemarina SA Hemarina is a biotechnology company that research and develop marine oxygen carriers for therapeutic and industrial uses. The company develops hemoglobinbased oxygen carriers HBOCs ...

Brest University Hospital and HEMARINA Present Positive New Advances from the Initial Clinical Trial of HEMO2life® at the American Transplant Congress in Seattle

Significant improvement in graft function Brest University Hospital and HEMARINA announced at a poster1 session at the American Transplant Congress (American ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "HEMARINA" on BioPortfolio

We have published hundreds of HEMARINA news stories on BioPortfolio along with dozens of HEMARINA Clinical Trials and PubMed Articles about HEMARINA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HEMARINA Companies in our database. You can also find out about relevant HEMARINA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record